High-Resolution Magnetic Resonance Imaging of Disparities in the Transcapillary Transfer Rates in Orthotopically Inoculated Invasive Breast Tumors

Cancer Research

Volumn 64, Issue 9, 2004, Pages 3155-3161

  Dadiani, Maya ^a   Margalit, Raanan ^a   Sela, Noa ^a   Degani, Hadassa ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM PENTETATE;

ALGORITHM; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; BLOOD VESSEL WALL; BREAST TUMOR; CANCER INVASION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DIFFUSION; FEMALE; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IMAGE PROCESSING; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION; PRESSURE GRADIENT; PRIORITY JOURNAL; TRANSPORT KINETICS; TUMOR GROWTH;

ANIMALS; BREAST NEOPLASMS; CAPILLARIES; CAPILLARY PERMEABILITY; CELL DIVISION; CELL LINE, TUMOR; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MICE; MICE, SCID; MODELS, ANIMAL; MODELS, BIOLOGICAL; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION;

EID: 2342447398     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-2665     Document Type: Article

References (39)

1. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000;6:389-95.
2. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature (Lond.) 2000;407:249-57.
3. Jain RK. Delivery of molecular and cellular medicine to solid tumors. Adv Drug Defiv Rev 2001;46:149-68.
4. Less JR, Posner MC, Boucher Y, Borochovitz D, Wolmark N, Jain RK. Interstitial hypertension in human breast and colorectal tumors. Cancer Res 1992;52:6371-4.
5. Aapro MS. Neoadjuvant therapy in breast cancer: can we define its role? Oncologist 2001;6:36-9.
6. Dixon JM, Anderson TJ, Miller WR. Neoadjuvant endocrine therapy of breast cancer: a surgical perspective. Eur J Cancer 2002;38:2214-21.
7. Degani H, Chetrit-Dadiani M, Bogin L, Furman-Haran E. Magnetic resonance imaging of tumor vasculature. Thromb Haemost 2003;89:25-33.
8. Leach MO. Application of magnetic resonance imaging to angiogenesis in breast cancer. Breast Cancer Res 2001;3:22-7.
9. Padhani AR. Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions. J Magn Reson Imaging 2002;16:407-22.
10. Knopp MV, Giesel FL, Marcos H, von Tengg-Kobligk H, Choyke P. Dynamic contrast-enhanced magnetic resonance imaging in oncology. Top Magn Reson Imaging 2001;12:301-8.
11. Furman-Haran E, Degani H. Parametric analysis of breast MRI. J Comput Assist Tomogr 2002;26:376-86.
12. Furman-Haran E, Grobgeld D, Degani H. Dynamic contrast-enhanced imaging and analysis at high spatial resolution of MCF7 human breast tumors. J Magn Reson 1997;128:161-71.
13. Gillies RJ, Bhujwalla ZM, Evelhoch J, et al. Applications of magnetic resonance in model systems: tumor biology and physiology. Neoplasia 2000;2:139-51.
14. Kelcz F, Furman-Haran E, Grobgeld D, Degani H. Clinical testing of high-spatial-resolution parametric contrast-enhanced MR imaging of the breast. AJR Am J Roentgenol 2002;179:1485-92.
15. Artemov D, Solaiyappan M, Bhujwalla ZM. Magnetic resonance pharmacoangiography to detect and predict chemotherapy delivery to solid tumors. Cancer Res 2001;61:3039-44.
16. Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusible tracer: standardized quantities and symbols. J Magn Reson Imaging 1999;10:223-32.
17. Tofts PS, Berkowitz B, Schnall MD. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model. Magn Reson Med 1995; 33:564-8.
18. Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997;7:91-101.
19. Pickup S, Zhou R, Glickson J. MRI estimation of the arterial input function in mice. Acad Radiol 2003;10:963-8.
20. Fritz-Hansen T, Rostrup E, Larsson HB, Sondergaard L, Ring P, Henriksen O. Measurement of the arterial concentration of Gd-DTPA using MRI: a step toward quantitative perfusion imaging. Magn Reson Med 1996;36:225-31.
21. Bhujwalla ZM, Artemov D, Natarajan K, Ackerstaff E, Solaiyappan M. Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts. Neoplasia 2001;3:143-53.
22. Judd RM, Reeder SB, May-Newman K. Effects of water exchange on the measurement of myocardial perfusion using paramagnetic contrast agents. Magn Reson Med 1999;41:334-42.
23. Landis CS, Li X, Telang FW, et al. Equilibrium transcytolemmal water-exchange kinetics in skeletal muscle in vivo. Magn Reson Med 1999;42:467-78.
24. Landis CS, Li X, Telang FW, et al. Determination of the MRI contrast agent concentration time course in vivo following bolus injection: effect of equilibrium transcytolemmal water exchange. Magn Reson Med 2000;44:563-74.
25. Larsson HB, Rosenbaum S, Fritz-Hansen T. Quantification of the effect of water exchange in dynamic contrast MRI perfusion measurements in the brain and heart. Magn Reson Med 2001;46:272-81.
26. Buckley DL. Transcytolemmal water exchange and its affect on the determination of contrast agent concentration in vivo. Magn Reson Med 2002;47:420-4.
27. Donahue KM, Weisskoff RM, Chesler DA, et al. Improving MR quantification of regional blood volume with intravascular T1 contrast agents: accuracy, precision, and water exchange. Magn Reson Med 1996;36:858-67.
28. Zimmerman JR, Brittin WE. Nuclear magnetic resonance studies in multiple phase systems: lifetime of a water molecule in an absorbing phase on silica gel. J Phys Chem 1957;61:1328-33.
29. Woessner DE. Nuclear transfer effects in nuclear magnetic resonance pulse experiments. J Chem Phys 1961;35:41-8.
30. Jain RK. Transport of molecules in the tumor interstitium: a review. Cancer Res 1987;47:3039-51.
31. Gordon MJ, Chu KC, Margaritis A, Martin AJ, Ethier CR, Rutt BK. Measurement of Gd-DTPA diffusion through PVA hydrogel using a novel magnetic resonance imaging method. Biotechnol Bioeng 1999;65:459-67.
32. Cranck J, editor. The mathematics of diffusion. London: Oxford University Press, 1964.
33. Jain RK. Understanding barriers to drug delivery: high resolution in vivo imaging is key. Clin Cancer Res 1999;5:1605-6.
34. Bogin L, Margalit R, Mispelter J, Degani H. Parametric imaging of tumor perfusion using flow- and permeability-limited tracers. J Magn Reson Imaging 2002;16: 289-99.
35. Boucher Y, Jain RK. Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse. Cancer Res 1992;52:5110-4.
36. Gutmann R, Leunig M, Feyh J, et al. Interstitial hypertension in head and neck tumors in patients: correlation with tumor size. Cancer Res 1992;52:1993-5.
37. Nathanson SD, Nelson L. Interstitial fluid pressure in breast cancer, benign breast conditions, and breast parenchyma. Ann Surg Oncol 1994;1:333-8.
38. Boucher Y, Baxter LT, Jain RK. Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy. Cancer Res 1990;50:4478-84.
39. Berk DA, Yuan F, Leunig M, Jain RK. Direct in vivo measurement of targeted binding in a human tumor xenograft. Proc Natl Acad Sci USA 1997;94:1785-90.